廣生堂(300436.SZ):擬使用募集資金向子公司增資以實施募投項目
格隆匯7月5日丨廣生堂(300436.SZ)公佈,公司於2021年7月5日召開第四屆董事會第四次會議和第四屆監事會第四次會議,審議通過了《關於使用募集資金向子公司增資以實施募投項目的議案》,為保障公司向特定對象發行股票募投項目的順利實施,基於募投項目實施主體情況及項目建設的實際需要,公司使用部分募集資金對全資子公司福建廣生堂金塘藥業有限公司(“金塘藥業”)和控股子公司江蘇中興藥業有限公司(“中興藥業”)進行增資。
金塘藥業是此次募投項目“原料藥製劑一體化生產基地建設項目”中原料藥生產基地建設項目的實施主體。為提高募集資金使用效率,加快推進募投項目的建設進度,公司將使用募集資金5000萬元對金塘藥業增資,增資款用於實施募投項目“原料藥製劑一體化生產基地建設項目”中原料藥生產基地建設項目。增資完成後,金塘藥業的註冊資本由5000萬元變更為10000萬元,公司仍持有其100%股權。
中興藥業是此次募投項目“江蘇中興製劑車間建設項目”的實施主體。為提高募集資金使用效率,加快推進募投項目的建設進度,公司將使用募集資金3000萬元對中興藥業增資。目前公司持有中興藥業92.5%股權,章之俊持有中興藥業7.5%股權。
根據中興藥業少數股東章之俊出具的《同意函》,經過協商,公司將按照中興藥業增資前估值為10500萬元為基礎計算增資價格,章之俊同意放棄此次按照同比例認繳出資的優先權利。增資完成後,中興藥業的註冊資本由5000萬元變更為6428.5714萬元,公司將持有其94.17%股權。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.